Scott Q. Harper

5.8k total citations · 2 hit papers
54 papers, 4.4k citations indexed

About

Scott Q. Harper is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Scott Q. Harper has authored 54 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 15 papers in Genetics and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Scott Q. Harper's work include Muscle Physiology and Disorders (30 papers), RNA Research and Splicing (16 papers) and Virus-based gene therapy research (12 papers). Scott Q. Harper is often cited by papers focused on Muscle Physiology and Disorders (30 papers), RNA Research and Splicing (16 papers) and Virus-based gene therapy research (12 papers). Scott Q. Harper collaborates with scholars based in United States, France and Belgium. Scott Q. Harper's co-authors include Beverly L. Davidson, Henry L. Paulson, Jeffrey S. Chamberlain, Nicolle H. Packer, Lesley Jones, Yi Xing, Steven Eliason, Inês Martins, Linda Yang and Qinwen Mao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Scott Q. Harper

54 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease

2008 559 citations Nicolle H. Packer, Yi Xing et al. Journal of Neuroscience profile →
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model

2005 528 citations Scott Q. Harper, Patrick D. Staber et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Scott Q. Harper

Since Specialization

Citations

This map shows the geographic impact of Scott Q. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Q. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Q. Harper more than expected).

Fields of papers citing papers by Scott Q. Harper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Q. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Q. Harper. The network helps show where Scott Q. Harper may publish in the future.

Co-authorship network of co-authors of Scott Q. Harper

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Q. Harper. A scholar is included among the top collaborators of Scott Q. Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Q. Harper. Scott Q. Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations 2024 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), (unknown), (unknown), Scott Q. Harper	7
2	Effective knockdown-replace gene therapy in a novel mouse model of DNM1 developmental and epileptic encephalopathy 2024 ·Molecular Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Amy N. Shore, (unknown), Wanqi Wang, Tristan T. Sands, Matthew C. Weston, Scott Q. Harper, Wayne N. Frankel	7
3	Post‐Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell Models 2023 ·Annals of Neurology ·Renatta Knox, Jocelyn O. Eidahl, Lindsay M. Wallace, Sarah G. Choudury, (unknown), (unknown), (unknown), Nizar Y. Saad, (unknown), Liwen Zhang, (unknown), Charles P. Emerson, Michael A. Freitas, Scott Q. Harper	3
4	A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice 2022 ·Journal of Clinical Investigation ·(unknown), Alexia Kagiava, Sarah G. Choudury, Matthew J. Jennings, Lindsay M. Wallace, (unknown), Amanda Heslegrave, Jan Richter, Christina Tryfonos, Christina Christodoulou, Henrik Zetterberg, Rita Horváth, Scott Q. Harper, Kleopas A. Kleopa	32
5	Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy 2021 ·Nature Communications ·Nizar Y. Saad, (unknown), (unknown), (unknown), (unknown), (unknown), Ryan L. Boudreau, Scott Q. Harper	28
6	Gene therapies for axonal neuropathies: Available strategies, successes to date, and what to target next 2020 ·Brain Research ·Kathryn H. Morelli, (unknown), Scott Q. Harper, Robert W. Burgess	9
7	RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model 2020 ·Molecular Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sabrina Petri, (unknown), Mu Yang, Scott Q. Harper, Wayne N. Frankel	25
8	Designed U7 snRNAs inhibit DUX4 expression and improve FSHD-associated outcomes in DUX4 overexpressing cells and FSHD patient myotubes 2020 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), (unknown), Nicolas Wein, Scott Q. Harper	22
9	Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD 2017 ·Molecular Therapy — Methods & Clinical Development ·Lindsay M. Wallace, Nizar Y. Saad, (unknown), (unknown), Jocelyn O. Eidahl, Jacqueline S. Domire, Danielle A. Griffin, Adam Herman, Zarife Sahenk, Louise R. Rodino‐Klapac, Scott Q. Harper	52
10	Aberrant Splicing in Transgenes Containing Introns, Exons, and V5 Epitopes: Lessons from Developing an FSHD Mouse Model Expressing a D4Z4 Repeat with Flanking Genomic Sequences 2015 ·PLoS ONE ·Eugénie Ansseau, Jacqueline S. Domire, Lindsay M. Wallace, Jocelyn O. Eidahl, (unknown), (unknown), (unknown), Alexandra Belayew, Scott Q. Harper	14
11	Dose-dependent Toxicity of Humanized Renilla reniformis GFP (hrGFP) Limits Its Utility as a Reporter Gene in Mouse Muscle 2013 ·Molecular Therapy — Nucleic Acids ·Lindsay M. Wallace, Andrew Moreo, K. Reed Clark, Scott Q. Harper	17
12	Construction of permanently inducible miRNA-based expression vectors using site-specific recombinases 2011 ·BMC Biotechnology ·(unknown), Adam Herman, Scott Q. Harper	3
13	The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease breakdown → 2008 ·Journal of Neuroscience ·Nicolle H. Packer, Yi Xing, Scott Q. Harper, Lesley Jones, Beverly L. Davidson	559
14	Lentivirus-Mediated RNA Interference in Mammalian Neurons 2008 ·Methods in molecular biology ·Scott Q. Harper, Pedro Gonzalez‐Alegre	8
15	Connecdenn, A Novel DENN Domain-Containing Protein of Neuronal Clathrin-Coated Vesicles Functioning in Synaptic Vesicle Endocytosis 2006 ·Journal of Neuroscience ·Patrick D. Allaire, Brigitte Ritter, Sébastien Thomas, Jonathon L. Burman, Alexei Yu. Denisov, Valérie Legendre‐Guillemin, Scott Q. Harper, Beverly L. Davidson, Kalle Gehring, Peter S. McPherson	55
16	RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model breakdown → 2005 ·Proceedings of the National Academy of Sciences ·Scott Q. Harper, Patrick D. Staber, Xiaohua He, Steven Eliason, Inês Martins, Qinwen Mao, Linda Yang, Robert M. Kotin, Henry L. Paulson, Beverly L. Davidson	528
17	CHIP Suppresses Polyglutamine Aggregation and ToxicityIn VitroandIn Vivo 2005 ·Journal of Neuroscience ·Victor M. Miller, Rick F. Nelson, Cynthia M. Gouvion, Aislinn Williams, Edgardo Rodríguez-Lebrón, Scott Q. Harper, Beverly L. Davidson, Michael R. Rebagliati, Henry L. Paulson	194
18	Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6 2004 ·Molecular Therapy ·Michael J. Blankinship, Paul Gregorevic, James M. Allen, Scott Q. Harper, Hollie A. Harper, Christine L. Halbert, A. Dusty Miller, Jeffrey S. Chamberlain	196
19	Adeno-Associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury 2004 ·Molecular Therapy ·Mingju Liu, Yongping Yue, Scott Q. Harper, Robert W. Grange, Jeffrey S. Chamberlain, Dongsheng Duan	146
20	Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy 2002 ·Nature Medicine ·Scott Q. Harper, Michael A. Hauser, Christiana DelloRusso, Dongsheng Duan, Robert W. Crawford, Stephanie F. Phelps, Hollie A. Harper, (unknown), John F. Engelhardt, Susan V. Brooks, Jeffrey S. Chamberlain	448

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact